1. Introduction to a Worldwide Problem
The long-term physical effects of viral infections present an unprecedented burden to global healthcare systems. Many millions suffer from debilitating symptoms many weeks or months after the acute phase of infection has resolved. This new chronic condition, with its many critical symptoms including extreme fatigue, cognitive disruptions, respiratory problems, and muscle pain, is clearly life-altering. The long-term damage caused to systems and the significantly reduced quality of life are an urgent call to the medical community for innovative solutions. Current medical practices are unable to effectively address the multitude of issues caused by Long COVID-19. The urgent need for new solutions is evident. The application of specialized stem cell therapy Thailand with UC-MSCs may provide a favorable method to address long-term cellular damage. By providing root cause closure to the biologic disruption, patients may regain their health as they were prior to the infection.
2. The Need to Understand the Complex Pathology
It is of utmost importance to the medical and scientific community that the biologic disruptions be defined. The Long COVID-19 syndrome is characterized by chronic inflammation and immune dysregulation and is a clear indication of the need for UC-MSCs through stem cell therapy Thailand. After the acute viral infection has cleared, the immune system often remains in a state of hyper-responsiveness. In some cases, a viral reservoir or remnants of the viral proteins may persist and cause a continuous response of hyper inflammation. This inflammation can create a hostile environment to an already healthy system. The thin layer of endothelial cells that comprise the blood vessels becomes damaged, leading to obstruction of the microvessels and necrosis of the affected tissues coupled with impaired delivery of oxygen. As a result, vital organs such as the lungs, heart and brain suffer from chronic hypoxia. Mitochondria suffer from the inability to generate sufficient cellular energy. This decline in cellular energy translates to a state of chronic fatigue for individuals suffering from the condition.
3. Limitations of Current Medical Practice
Current medical practices primarily focus on the alleviation of visible symptoms, rather than addressing the cellular deficits that remain. As a result, patients typically receive combinations of corticosteroids, bronchodilators, and analgesics that offer relief from the symptoms. However, these treatments come with side effects and they offer no long-term benefits. Treatments merely suppress the immune response, or cause artificial dilatation of the bronchi, and both of these options fail to treat the significant structural damage that is caused by Long COVID-19. The continued use of these strong immunosuppressive therapies has a consequence of significant metabolic derangement and progressive loss in bone density. Further, these approaches fail to address the widespread damage to the endothelial cells and the impaired mitochondrial function. The failure of standard care to address the needs of patients leaves a gap in the provision of care and demonstrates the essential requirement for alternatives that are truly restorative such as stem cell therapy Thailand utilizing UC-MSCs.
4. Justification for Highly Advanced Regenerative Modalities
The use of UC-MSCs in a therapeutic role represents an immense biological advantage when compared to standard therapies. These biological systems with powerful immunity-modulating function are exceptional in their design for use in addressing Long COVID-19 via stem cell therapy Thailand. After intravenous administration, they have the ability of directed, specific homing, to impaired and inflamed tissues. Once sources of injury have been identified, paracrine signaling stimulates concentrated biosynthesis of secretome which contains extracellular vesicles, growth factors, and cytokines. The biological component of this secretome also stimulates the aggressive microglial response in the nervous system to halt neuroinflammation. Macrophages are also adapted from their inflammatory response to a state of cellular repair. These paracrine signaling molecules also stimulate the growth of new blood vessels to increase blood perfusion and vascular repair to sustain cellular health.
Figure 1: Comparing limitations of current practice and Advanced regenerative solutions with UC-MSCs in Long COVID-19
5. The Surge of Regenerative Medicine in South East Asia
There are few countries in the world that have the modern medical and technological infrastructure capable of performing stem cell therapy Thailand in a safe and efficient manner, and few countries that have the skilled personnel. In addition, Thailand has a well-established regulatory framework to ensure high quality research. Regenerative medicine, especially the use of UC-MSCs, can be aided by other therapies, such as improvement in nutrition and decrease in toxins, in order to enhance the effects of the stem cells being administered. In addition, the quality of the stem cells can be optimally controlled by regulating the environment that the cells are expanded in. These cells can be well positioned to treat Long COVID-19 and other post-viral conditions that are prevalent in other areas of the world and that are hard to treat because they are not well understood.
6. Restoration of Cellular Function
Conventional pharmacology lacks the ability to provide cellular repair in conjunction with relief of the symptoms caused from the complex inflammatory condition triggered by Long COVID-19. The integration of UC-MSCs and stem cell therapy Thailand allows medical professionals an innovative way to tackle issues related to tissue degeneration and systemic inflammation. Stem cell therapy is an advanced medical therapy for people who want to restore their health. This minimally invasive cellular therapy has the potential to repair damaged neural pathways and restore the barriers of blood vessels. The evolving automated biological technologies will reshape the methods of healing the chronically ill.